Applied Relaxation (AR) Technique Versus Its Modified Version for Treating Menopausal Symptoms
Study Details
Study Description
Brief Summary
The purpose of this study is to demonstrate better efficacy and effectiveness of modified applied relaxation technique over its original version for treating menopausal symptoms.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Detailed Description
Applied Relaxation (AR) is the most commonly used behavioral methods for treating menopausal symptoms. Many clinical trials reported that the technique effectively improved vasomotor and related symptoms. There is a strong evidence to support its continue use in clinical settings.
However, the original AR technique is too cumbersome. It involves intensive training once a week for 12 consecutive weeks. Each weekly session takes 60 minutes, and subjects are requested to do self-practice at home for at least 15-20 minutes/day. As such, >25% of recruited subjects drop out from the training course. The investigators have modified the original AR technique by reducing the duration of training to only once, lasting 60 minutes. Participants are requested to do self-practice at home for 15-20 minutes/day as in the original technique. Instead of coming to a weekly class, the investigators use telephone to communicate with the subjects once a week for 12 consecutive weeks. A preliminary study showed all 10 recruited subjects remained in the study (MR; modified relaxation technique) until completion. They all reported dramatic improvement in their vasomotor symptoms.
In this study, the investigators propose to compare our modified version of AR with the original method in a randomized controlled clinical trial. The subjects will be Thai menopausal women with vasomotor symptoms. The main outcomes are the reduction in the MRS score (intensity of hot flushes, night sweats and sleep disturbances) among those who remain in the program at the end of the study (efficacy evaluation). As nearly all patients will remain in the MR group, while >25% of those in the AR group will be expected to drop out from the study, the investigators should be able to demonstrate a superiority of MR over AR in terms of effectiveness as well.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Applied Relaxation (AR)
|
Behavioral: Applied Relaxation (AR)
Participants will receive 12 sessions AR training. After that they will asked to practice at home once a day for 15-20 minutes during their leisure times, at least 5 days a week for the whole 12 weeks of the follow-up period.
Other Names:
|
| Experimental: Modified Relaxation (MR)
|
Behavioral: Modified Relaxation (MR)
The MR technique is modified from the AR technique that will require participants to attend only 1 session, lasting 60 minutes. After the training session, participants will be given a hand-out on MR. They will continue to practice MR at home once a day for 15-20 minutes during their leisure times, at least 5 days a week for the whole 12 weeks of the follow-up period.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Changes in global scores of Menopausal Rating Scale (MRS). [12 weeks]
MRS measure after intervention at 1, 2 and 3 months for follow-up.
Secondary Outcome Measures
- Change in the frequency and severity of hot flushes. [12 weeks]
Measure the frequency and severity of hot flushes after intervention at 1, 2 and 3 months.
- Change in the frequency and severity of night sweats. [12 weeks]
Measure the frequency and severity of night sweats after intervention at 1, 2, and 3 months.
- Change in the frequency and severity of sleep disturbances. [12 weeks]
Measure the frequency and severity of sleep disturbances after intervention at 1, 2, and 3 months.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Perimenopausal women and postmenopausal women with either surgical or spontaneous menopause.
-
Women who have at least 5 points of MRS score.
Exclusion Criteria:
-
Women who are taking any hormone therapy for any reason in the past three months prior to entering the trails.
-
Women with uncontrolled hypertension (>95mmHg diastolic pressure) or daily use of sedatives, tranquilizer or antidepressant medication.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Mahassarakham Hospital | Maha Sarakam | Northeast | Thailand | 44000 |
Sponsors and Collaborators
- Chiang Mai University
Investigators
- Principal Investigator: Suprawita - Saensak, PhDcandidate, PhD in Clinical Epidemiology Program, Faculty of Medicine, Chiang Mai University (Thailand)
Study Documents (Full-Text)
None provided.More Information
Additional Information:
- NIH is the nation's medical research agency-supporting scientific studies that turn discovery into health.
- PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books.
- Elsevier is committed to making genuine contributions to the science and health communities.
- The Journal of The North American Menopause Society is a peer-reviewed scientific journal owned by NAMS and published by Lippincott Williams & Wilkins (LWW).
- The International Journal of Clinical and Health Psychology.
Publications
None provided.- ARMR-Sympts